Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-01-11

Clinical Trial Update: Betadine Pleurodesis Via Tunneled Pleural Catheters [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Betadine pleurodesis via tunneled pleural catheters was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betadine pleurodesis via tunneled pleural catheters

Snippet

Sponsor: Yale University | Conditions: Pleural Effusion, Pleurodesis | Phase 4 | Status: WITHDRAWN